Shield’ Blood Test for Colorectal Cancer Added to U.S. NCCN Guidelines — Korean Launch Nears

2025.07.15

NGS to Reduce Infectious Disease Diagnosis from 33 Days to 3 — Clinical Application Imminent

2025.07.01

다우바이오메디카, 폐암 치료 모니터링 CTC 액체생검 기술 소개 l Lung Cancer Monitoring with CTC Liquid Biopsy: Dow Biomedica Highlights Innovative Technology"

2025.06.25

다우바이오메디카 “대장암 선별검사 ‘쉴드’ 국내 상용화” ㅣ Dow Biomedica Introduces ‘Shield’ Colorectal Cancer Screening Test to Korean Market

2025.06.17

서울대병원 연구팀, 혈액검사로 위암 고위험군 조기 선별 가능성 제시 l SNU Hospital Team Suggests Blood Test Could Identify High-Risk Gastric Cancer Patients Early

2025.05.26

재발률 높은 방광암, 유전자 검사로 재발 확인 가능 l Bladder Cancer Prone to Recurrence Can Now Be Monitored Through Genetic Testing

2025.05.20

Dow Biomedica Unveils Non-Invasive Genetic Test for Early Detection of Kidney Transplant Complications

2025.05.07

다발골수종 정밀 진단 시대...핵심은 ‘MRD 감지 l Advanced MRD Detection Marks New Era in Precision Diagnostics for Multiple Myeloma

2025.04.24

Dowbiomedica introduce CTC Testing at the KSLM Conference

2025.04.17

위축성 위염, 조직검사 없이도 선별 가능 시대 '개막' ㅣ A New Era in Atrophic Gastritis Screening Without Biopsy

2025.03.28

다우바이오메디카, 진단혈액학회에서 CTC 검사 소개 ㅣIntroducing CTC Test at the Spring Conference of the Korean Society for Diagnostic Hematology

2025.03.18

대표님, 시현실 신인상 수상 소식 전해드립니다 l Our CEO Honored with the 2025 Rookie Poet Award

2025.03.06